Review



additional covid  (Lee Biosolutions)


Bioz Verified Symbol Lee Biosolutions is a verified supplier
Bioz Manufacturer Symbol Lee Biosolutions manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 92
      Buy from Supplier

    Structured Review

    Lee Biosolutions additional covid
    Additional Covid, supplied by Lee Biosolutions, used in various techniques. Bioz Stars score: 92/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/additional covid/product/Lee Biosolutions
    Average 92 stars, based on 2 article reviews
    additional covid - by Bioz Stars, 2026-03
    92/100 stars

    Images



    Similar Products

    additional covid 19 therapy  (Gilead Sciences)
    97
    Gilead Sciences additional covid 19 therapy
    Additional Covid 19 Therapy, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/additional covid 19 therapy/product/Gilead Sciences
    Average 97 stars, based on 1 article reviews
    additional covid 19 therapy - by Bioz Stars, 2026-03
    97/100 stars
    		  Buy from Supplier
    additional covid 19 treatments  (Gilead Sciences)
    97
    Gilead Sciences additional covid 19 treatments
    Patient characteristics and outcomes in the whole cohort and in two groups, inpatient and outpatient, based on the location of passive antibody therapy administration.
    Additional Covid 19 Treatments, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/additional covid 19 treatments/product/Gilead Sciences
    Average 97 stars, based on 1 article reviews
    additional covid 19 treatments - by Bioz Stars, 2026-03
    97/100 stars
    		  Buy from Supplier
    covid-19 booster/additional dose  (Optum Inc)
    90
    Optum Inc covid-19 booster/additional dose
    Patient characteristics and outcomes in the whole cohort and in two groups, inpatient and outpatient, based on the location of passive antibody therapy administration.
    Covid 19 Booster/Additional Dose, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/covid-19 booster/additional dose/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    covid-19 booster/additional dose - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    additional covid 19  (Gilead Sciences)
    97
    Gilead Sciences additional covid 19
    Characteristics of 361 solid organ transplant recipients treated with bebtelovimab or sotrovimab for mild‐to‐moderate <t> coronavirus disease 2019 </t> (COVID‐19)
    Additional Covid 19, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/additional covid 19/product/Gilead Sciences
    Average 97 stars, based on 1 article reviews
    additional covid 19 - by Bioz Stars, 2026-03
    97/100 stars
    		  Buy from Supplier
    additional anti covid 19 agents  (Gilead Sciences)
    97
    Gilead Sciences additional anti covid 19 agents
    Characteristics of 361 solid organ transplant recipients treated with bebtelovimab or sotrovimab for mild‐to‐moderate <t> coronavirus disease 2019 </t> (COVID‐19)
    Additional Anti Covid 19 Agents, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/additional anti covid 19 agents/product/Gilead Sciences
    Average 97 stars, based on 1 article reviews
    additional anti covid 19 agents - by Bioz Stars, 2026-03
    97/100 stars
    		  Buy from Supplier
    additional covid  (Lee Biosolutions)
    92
    Lee Biosolutions additional covid
    Characteristics of 361 solid organ transplant recipients treated with bebtelovimab or sotrovimab for mild‐to‐moderate <t> coronavirus disease 2019 </t> (COVID‐19)
    Additional Covid, supplied by Lee Biosolutions, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/additional covid/product/Lee Biosolutions
    Average 92 stars, based on 1 article reviews
    additional covid - by Bioz Stars, 2026-03
    92/100 stars
    		  Buy from Supplier

    Image Search Results


    Patient characteristics and outcomes in the whole cohort and in two groups, inpatient and outpatient, based on the location of passive antibody therapy administration.

    Journal: Diseases

    Article Title: A Descriptive, Retrospective Analysis of COVID-19 Passive Antibody Therapy and Its Effects on Morbidity and Mortality in Patients Receiving B-Cell-Depleting Therapies

    doi: 10.3390/diseases12020033

    Figure Lengend Snippet: Patient characteristics and outcomes in the whole cohort and in two groups, inpatient and outpatient, based on the location of passive antibody therapy administration.

    Article Snippet: Hospitalized patients were also more likely to receive additional COVID-19 treatments: 74% of patients received remdesivir, 69% received corticosteroids, and 4% received tocilizumab ( ).

    Techniques:

    Characteristics of 361 solid organ transplant recipients treated with bebtelovimab or sotrovimab for mild‐to‐moderate coronavirus disease 2019 (COVID‐19)

    Journal: Transplant Infectious Disease

    Article Title: Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild‐to‐moderate coronavirus disease 2019 during the Omicron epoch

    doi: 10.1111/tid.13901

    Figure Lengend Snippet: Characteristics of 361 solid organ transplant recipients treated with bebtelovimab or sotrovimab for mild‐to‐moderate coronavirus disease 2019 (COVID‐19)

    Article Snippet: Nine admitted patients received additional COVID‐19‐directed therapy, including remdesivir ( N = 7), corticosteroids ( N = 7), and tocilizumab ( N = 1).

    Techniques: